About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US

Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US

by Lakshmi Darshini on Aug 31 2015 5:29 PM

The approval for Aurobindo Pharma’s Raloxifene Hydrochloride tablets is for strength of 60 mg that is therapeutically equivalent to Evista, 60 mg of Eli Lilly.

Indian Pharma Gets USFDA Approval To Market Tablets To Treat Osteoporosis In The US

The US Food and Drug Administration (USFDA) has approved Indian drug firm, Aurobindo Pharma, to manufacture and market its generic version of Eli Lilly's Evista tablets used to treat and prevent osteoporosis in postmenopausal women.

The approval by the USFDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.

Benefits of a New Osteoporosis Drug Enhanced by 'Unsung' Cells

Benefits of a New Osteoporosis Drug Enhanced by 'Unsung' Cells
A scientifically overlooked group of cells are likely crucial to the process of bone loss.

The product has an estimated market size of USD 404 million for the 12 months ended June 2015, the company added, citing IMS data. This is the 45th Abbreviated New Drug Application (ANDA) to be approved out of Unit VII formulation facility in Hyderabad for manufacturing oral non-antibiotic products.

Aurobindo now has a total of 210 ANDA approvals, 182 final ones, including 9 from Aurolife Pharma LLC and 28 tentative approvals from US FDA, it added.

Source-PTI

Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US

Aurobindo Pharma Get FDA Nod for Marketing Nafcillin Injections in US
Aurobindo Pharma revealed that it has received an approval from the US Food and Drug Administration to market Nafcillin injections

Aurobindo Pharma Receives FDA Approval to Market Generic Narcolepsy Drug

Aurobindo Pharma Receives FDA Approval to Market Generic Narcolepsy Drug
Aurobindo Pharma revealed that it has received approval from the US Food and Drug Administration to manufacture modafinil tablets in the US.

Risky Osteoporosis Drug may be Suspended

Risky Osteoporosis Drug may be Suspended
An osteoporosis drug, apparently risky, including the risk of heart attacks, may now be suspended by a committee in Europe

Recommended Readings

Back Pain at Workplace: Prevention and Exercises

Back Pain at Workplace: Prevention and Exercises

Understanding the basics about our back and our posture is very important in preventing back pain and improving workplace productivity.

Fracture

A fracture is a condition where the continuity of the bone is lost. Majority of bone fractures occur because of high force impact or stress on a bone.

Foods that Negatively Affect Bone Density

Foods that Negatively Affect Bone Density

Calcium and vitamin D are known to improve bone health. Most people are aware of the foods which promote bone health but are unaware of those that lower bone density leading to osteoporosis.

Colle’s Fracture

Colle’s Fracture

Colles fracture or broken wrist is a wrist fracture, which occurs within an inch of the wrist joint. Colles fracture involves the forearm bone’s distal end of the radius.

Skeletal Fluorosis

Skeletal Fluorosis

Skeletal fluorosis a chronic bone disease means excessive accumulation of fluoride in the bones and joints for the long term that can lead to a crippling condition.

Female Athlete Triad

Female Athlete Triad

Female athlete triad is caused by extreme dieting and exercise usually among young women athletes and leads to abnormal menstruation, an unhealthy body and in extreme cases even death.

Latest Drug News

Weight Loss Drug Tirzepatide Demonstrates Diabetes Prevention

Weight Loss Drug Tirzepatide Demonstrates Diabetes Prevention

Tirzepatide, a weight loss drug, shows promise in preventing diabetes by improving insulin sensitivity and aiding in weight management.

Take Home Naloxone Program Expands in Australia

Take Home Naloxone Program Expands in Australia

Discover how free Naloxone nasal spray is saving lives by reversing opioid toxicity in emergencies and the THN program expanding access in Australia.

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

Explore the groundbreaking obe-cel CAR T cell therapy for relapsed B-cell ALL, showcasing high efficacy and FDA approval as a promising treatment option.

Study Finds Popular Diabetes and Obesity Drugs Also Safeguard Kidneys

Study Finds Popular Diabetes and Obesity Drugs Also Safeguard Kidneys

A new study shows GLP-1 receptor agonists offer significant protection for kidneys and heart in both diabetic and non-diabetic individuals.

Pink Cocaine: The Party Drug With a Deadly Twist

Pink Cocaine: The Party Drug With a Deadly Twist

Pink cocaine: the glamorous party drug trend with a fatal twist. It is typically a powdered blend of ketamine and illicit substances, often dyed with food coloring.

Advertisement